Pacer Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Pacer Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,016	Closed	-$16K	–	3802
2024 Q1	$16K	Buy	+1,016	New	+$15.6K	﹤0.01%	3481
2021 Q2	–	Sell	-1,798	Closed	-$81K	–	1578
2021 Q1	$81K	Sell	1,798 -428	-19%	-$19.9K	﹤0.01%	1317
2020 Q4	$127K	Buy	2,226 +288	+15%	+$17.1K	﹤0.01%	1325
2020 Q3	$99K	Buy	+1,938	New	+$94.9K	﹤0.01%	1251
2018 Q4	–	Sell	-1,544	Closed	-$60K	–	1087
2018 Q3	$60K	Buy	+1,544	New	+$57.1K	﹤0.01%	1134

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Pacer Advisors's DCPH Position: Q2 2024 in Review

Pacer Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,016 shares — an estimated $16K sold.

Pacer Advisors first reported a position in DCPH in Q3 2018 and held it in 5 quarters. The position peaked at $127K in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Pacer Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Pacer Advisors sold 1,016 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $16K.
Pacer Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Pacer Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $127K in Q4 2020.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.